Acute wound care market seen reaching $13.68 billion by 2035

The global acute wound care market is projected to grow from $9.14 billion in 2026 to $13.68 billion by 2035, driven by higher surgical volumes, reimbursement expansion and broader use of advanced dressings and negative pressure wound therapy. North America leads now, while Asia-Pacific is expected to grow fastest through 2035.

Why it matters: - Higher surgical volumes are expanding demand for wound closure, post-operative care and infection control products. - Reimbursement changes are pushing hospitals, ambulatory surgical centers and home-care providers toward advanced wound care products. - The market shift affects procurement, payer costs and where wound care is delivered.

What happened: - Market Research Future projects the global acute wound care market will rise from $9.14 billion in 2026 to $13.68 billion by 2035. - The forecast implies a 4.72% compound annual growth rate from 2026 to 2035. - The market base was estimated at $8.73 billion in 2025. - The company published the estimate on June 11, 2026. - A free sample and detailed report are available.

The details: - The report ties growth to rising global surgical volumes, expanded reimbursement and a shift from gauze-and-tape care to advanced wound therapies. - The WHO recorded more than 310 million major surgical procedures annually as of 2024, with orthopedic and cardiovascular cases growing fastest. - U.S. Centers for Medicare & Medicaid Services payment changes in FY 2024 exceeded $1.2 billion for bundled payment modifications tied to post-surgical wound management. - U.S. ambulatory surgical center volumes increased 7.3% year over year in 2024. - CMS expanded bundled payment coverage in January 2024 for NPWT rentals and advanced wound healing dressings for home-care patients. - Advanced wound products cited in the report include foam, hydrocolloid and alginate dressings, plus antimicrobial wound therapy and NPWT systems. - Closed-incision NPWT has moved into broader use across cardiac, abdominal and cesarean incisions. - A 2024 meta-analysis in the Journal of Wound Care found single-use NPWT systems supported closure of high-risk surgical incisions with low complications and SSI rates. - The global NPWT device segment is expected to grow at more than 5.9% CAGR through 2035. - Antimicrobial wound care is getting a lift from rising antimicrobial resistance, which GLASS data links to an estimated 1.27 million deaths annually and nearly 5 million deaths overall. - Bioactive dressings using silver, polyhexamethylene biguanide, medical-grade honey, collagen, hyaluronic acid and growth factor delivery systems are gaining share. - The regenerative dressings opportunity is estimated at more than $1.5 billion by 2035.

Between the lines: - The market is being pulled by policy and procedure volume, not by discretionary healthcare spending. - The reimbursement expansion favors products that move care out of hospitals and into outpatient and home settings. - Group purchasing organizations are pressuring manufacturer margins even as they widen access to advanced dressings. - The competitive field is concentrated in premium advanced wound care and NPWT, while low-cost suppliers still win price-sensitive tenders. - The report estimates that by 2030, 40% of acute wound care products will include digital measurement or predictive analytics. - The same forecast expects home-care wound management to exceed 22% of total acute wound care revenue by 2035, up from about 15% in 2025.

What’s next: - Hospitals, ambulatory centers and home-care providers are expected to keep adopting portable NPWT and antimicrobial dressings through 2035. - AI-powered wound assessment tools are expected to become more common in wound care workflows by 2030. - Needle-free and portable NPWT devices are expected to broaden the addressable market beyond inpatient settings. - North America is projected to remain the largest market, while Asia-Pacific is forecast to grow fastest at 6.52% CAGR from 2026 to 2035. - The report identifies 3M Healthcare (Solventum), Smith+Nephew, Mölnlycke Health Care, ConvaTec and Coloplast among key companies in the market. - More related research is available on advanced wound care management, wound care and negative pressure wound therapy.

The bottom line: - Acute wound care is shifting from basic dressings to higher-value advanced therapies, with reimbursement and outpatient surgery volumes doing most of the heavy lifting.